Breuhahn, Kai 1969-
Kai Breuhahn researcher
VIAF ID: 13200464 ( Personal )
Permalink: http://viaf.org/viaf/13200464
Preferred Forms
- 100 1 _ ‡a Breuhahn, Kai ‡d 1969-
- 100 1 _ ‡a Breuhahn, Kai ‡d 1969-
- 100 0 _ ‡a Kai Breuhahn ‡c researcher
4xx's: Alternate Name Forms (3)
5xx's: Related Names (3)
- 510 2 _ ‡a Heidelberg, Univ
- 510 2 _ ‡a Pathologisches Institut
- 510 2 _ ‡a Universität Heidelberg ‡b Pathologisches Institut ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
Acquired resistance to antiangiogenic therapies in hepatocellular carcinoma is mediated by yes‐associated protein 1 activation and transient expansion of stem‐like cancer cells | |
Induktion eines sekretorischen Phänotyps durch das Onkogen YAP in der Leberkarzinogenese | |
Molekulare Progressionsmechanismen der humanen Hepatokarzinogenese | |
Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon | |
A systems biology study on NFκB signaling in primary mouse hepatocytes | |
TTCA: an R package for the identification of differentially expressed genes in time course microarray data | |
Untersuchungen zur Funktion von GM-CSF in der chemisch induzierten Hautkarzinogenese im transgenen Mausmodell | |
Validation and characterization of monoclonal antibodies to target cancer stem cells and to develop new anti-cancer therapies | |
Validierung und Charakterisierung von monoklonalen Antikörpern zur zielgerichteten Behandlung von Krebsstammzellen und zur Entwicklung neuer Krebstherapien | |
Yes-associated protein (YAP)-dependent overexpression of the spliceosome regulator U2AF Homology Motif Kinase 1 (UHMK1) promotes cell cycle progression in human liver cancer |